Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:23 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000856982-26-000025
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net income | $40,995 | $30,147 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 30,496 | 29,292 |
| Gain on disposition of business | (12,502) | — |
| Share of equity investee loss | 531 | — |
| Loss on sale or abandonment of property and equipment | 67 | 87 |
| Write-off of certain intangible assets and other long-term assets | 137 | 32 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Merit Medical Systems's D&A?
- Merit Medical Systems (MMSI) reported D&A of $30.5M in Q1 2026.
- How has Merit Medical Systems's D&A changed year-over-year?
- Merit Medical Systems's D&A increased by 4.1% year-over-year, from $29.29M to $30.5M.
- What is the long-term trend for Merit Medical Systems's D&A?
- Over 4 years (2021 to 2025), Merit Medical Systems's D&A has grown at a 10.0% compound annual growth rate (CAGR), from $84.07M to $123.17M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Merit Medical Systems's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude